Related Information

Stay connected. Sign up now to be informed of the latest FasterCures blogs, events and program updates.

 

Strategic Plan

 Paving the way to a more effective and efficient research enterprise, FasterCures works across all sectors and diseases to transform the way we pursue, fund, and conduct medical research. 

We focus our strategic priorities and programmatic efforts on three goals that we believe must transform in order to catalyze a more effective and efficient medical research system:

Download a PDF of the FasterCures Strategic Plan

Foster innovation and accountability across research organizations

  • Accelerating analysis and dissemination of best practices in the funding and conduct of medical research
    FasterCures learned firsthand from medical research foundations that are part of its TRAIN (The Research Acceleration and Innovation Network) initiative that big ideas can come from small spaces. We’ve seen how new business models are accelerating research; and we seek to maximize the productivity and impact of these groups so best practices are adopted broadly and can become the new standard.
  • Facilitating informed investment in medical philanthropy through analytical tools and resources The FasterCures Philanthropy Advisory Service (PAS) is a resource designed to help philanthropists understand and evaluate the research and development landscape and strategically guide their investment in high-impact disease research. FasterCures will continue to expand the scope and breadth of PAS to increase its value to the donor community while also cultivating greater accountability, transparency, and efficiency at nonprofits.
  • Promoting innovative collaborations among leading players in the research enterprise
    Partnering for Cures, an annual FasterCures conference, facilitates matchmaking and idea sharing among medical philanthropists, patient-driven research foundations, and biotechnology and pharmaceutical companies to ignite partnerships needed to turn an idea into an accessible medical solution.

Improve and continuously modernize the medical research environment

  • Enhancing capacity at and resources available to the Food and Drug Administration (FDA) for acceleration of cures
    Working across sectors, FasterCures helps advocate for an FDA fully equipped with the resources and expertise it needs to keep pace with the changing research technology and to apply 21st Century scientific principles to regulatory practices and policies.
  • Supporting innovative programs, practices, and policies at the National Institutes of Health (NIH)
    The NIH, the single largest sponsor of biomedical research in the world, continues to guide both publicly and privately funded research. Working with key stakeholders, FasterCures has focused on maximizing the effectiveness of NIH’s Intramural Research Program, an important national resource. We will continue to identify ways to support innovation and innovators within the Institutes and, through its grantmaking, at academic institutions around the country.
  • Improving support for translational research across a variety of settings
    Translational research is the critical bridge between basic and clinical research, yet remains poorly defined and under-resourced. FasterCures will advance efforts that bring a sense of urgency to the medical research community, policymakers,  and the general public regarding the need to conduct more and better bench-to-bedside translational research.

Maximize the development and use of research resources 

  • Developing and enhancing efforts to empower patients to become more engaged in research through biospecimen donation, electronic data sharing, and clinical trials
    Embedded within each individual is information – medical records, biological material such as tissue, blood, and DNA – that is crucial to understanding and managing disease. But too often that information remains isolated, unknown, and unavailable to researchers. FasterCures developed its PHD (Patients Helping Doctors) program to identify ways to engage more patients and healthy volunteers in clinical research. The PHD program seeks to drive greater awareness of the value and need for biospecimens, ensure that research is a consideration in the development of a national health information network, and promote strategies for conducting more efficient and effective clinical trials.  
     

Each of our programs and initiatives have been designed and developed to bring us closer to achieving these goals. Learn more.